Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Assessment of measurable residual disease (MRD) in adult patients with acute lymphocytic leukemia: best use and a case report. Clinical advances in hematology & oncology : H&O Muffly, L. 2020; 18 Suppl 9 (3): 10-14
View details for PubMedID 33843878